Document Detail


Transversus abdominis plane (TAP) catheters inserted under direct vision in the donor site following free DIEP and MS-TRAM breast reconstruction: A prospective cohort study of 45 patients.
MedLine Citation:
PMID:  23142025     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
INTRODUCTION: The transversus abdominis plane (TAP) block is a peripheral nerve block of T6-L1 intercostal nerves of the abdominal wall. The purpose of this study was to evaluate the usefulness of intermittent TAP blockade for the first two postoperative days following free muscle sparing-transverse rectus abdominis muscle (MS-TRAM) or deep inferior epigastric perforator (DIEP) flap reconstruction of the breast. Therapeutic - Level II evidence. MATERIAL AND METHODS: This prospective cohort consisted of 45 consecutive patients who underwent DIEP or MS-TRAM free-flap breast reconstruction. Intra-operatively, a multi-orifice epidural catheter was inserted under direct vision into the TAP. Ten millilitres of 0.25% bupivacaine was injected into each TAP catheter every 12 h until removal on day 3. The control group consisted of 80 consecutive patients who underwent free MS-TRAM or DIEP free-flap breast reconstructions by the same two surgeons without TAP block. Postoperatively, both groups had patient-controlled analgesia (PCA) and the primary outcome was intravenous (IV) PCA opioid consumption in the first 48 h. RESULTS: There were no complications associated with using TAP catheters. The 48-h PCA-delivered opioid requirement was significantly less (p < 0.001) in the TAP block group (17.10 ± 17.23 mg IV morphine equivalent) compared to the control group (48.44 ± 39.53 mg). CONCLUSION: Intermittent delivery of bupivacaine through the TAP block significantly reduced postoperative parenteral opioid requirements following free MS-TRAM or DIEP flap reconstruction of the breast. This is the first report of the TAP block being inserted under direct vision to provide postoperative analgesia at the abdominal flap donor site following microsurgical breast reconstruction.
Authors:
Toni Zhong; Karen W Wong; Homan Cheng; Marie Ojha; Coimbatore Srinivas; Stuart A McCluskey; Hance Clarke; Lindsay Jacks; Stefan O P Hofer
Related Documents :
17375315 - Intraoperative parathormone measurement from the internal jugular vein predicts post-th...
10493485 - Intrinsic limitations to unilateral parathyroid exploration.
24576975 - Modified criteria for the systemic inflammatory response syndrome (sirs) improves their...
23215535 - Repair of the donor areas defects after split thickness skin grafts utilizing an advanc...
19070555 - Partial splenic embolization for hypersplenism in cirrhosis: a long-term outcome in 62 ...
24495895 - Treatment and prognosis in peptic ulcer bleeding.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-8
Journal Detail:
Title:  Journal of plastic, reconstructive & aesthetic surgery : JPRAS     Volume:  -     ISSN:  1878-0539     ISO Abbreviation:  J Plast Reconstr Aesthet Surg     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101264239     Medline TA:  J Plast Reconstr Aesthet Surg     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.
Affiliation:
Division of Plastic and Reconstructive Surgery, University Health Network, Toronto, Ontario, Canada; Division of Plastic and Reconstructive Surgery, University of Toronto, Toronto, Ontario, Canada. Electronic address: toni.zhong@uhn.ca.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  320-Detector row CT angiography for detection and evaluation of intracranial aneurysms: Comparison w...
Next Document:  MicroRNA-1 targets Slug and endows lung cancer A549 cells with epithelial and anti-tumorigenic prope...